Literature DB >> 27866122

Synthesis, characterization and radiolabeling of folic acid modified nanostructured lipid carriers as a contrast agent and drug delivery system.

Eser Ucar1, Serap Teksoz2, Cigdem Ichedef1, Ayfer Yurt Kilcar1, E Ilker Medine1, Kadir Ari1, Yasemin Parlak3, B Elvan Sayit Bilgin3, Perihan Unak1.   

Abstract

Nanostructured lipid carriers (NLCs) are the new generation of solid lipid drug delivery systems. Their suitability as contrast agents for gamma scintigraphy is an attracting major attention. The aim of current study was to prepare surface modified nanostructured lipid carrier system for paclitaxel (PTX) with active targeting and imaging functions. In accordance with the purpose of study, PTX loaded nanostructured lipid carriers (NLCs) prepared, modified with a folate derivative and radiolabeled with technetium-99m tricarbonyl complex (99mTc(CO)3+). Cellular incorporation ratios of radiolabeled nanoparticles (99mTc(CO)3-PTX-NLC) were investigated in vitro on three cancer cell lines. Additionally in vivo animal studies conducted to evaluate biological behavior of 99mTc(CO)3-PTX-NLC on female Wistar Albino rats. Biodistribution results showed that the folate derivative modified 99mTc(CO)3-PTX-NLC had considerably higher uptake in folate receptor positive organs. The data obtained from present study could be useful in the design of biodegradable drug carriers of PTX and folate receptor based tumor imaging agents. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biodistribution; Cell culture; Nanostructured lipid carriers; Paclitaxel; Radiolabeling; Technetium-99m

Mesh:

Substances:

Year:  2016        PMID: 27866122     DOI: 10.1016/j.apradiso.2016.11.002

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  3 in total

1.  The effect of radiolabeled nanostructured lipid carrier systems containing imatinib mesylate on NIH-3T3 and CRL-1739 cells.

Authors:  Evren Atlihan Gundogdu; Emine Selin Demir; Meliha Ekinci; Emre Ozgenc; Derya Ilem Ozdemir; Zeynep Senyigit; Makbule Asikoglu
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 2.  Antineoplastics Encapsulated in Nanostructured Lipid Carriers.

Authors:  Gustavo Henrique Rodrigues da Silva; Ludmilla David de Moura; Fabíola Vieira de Carvalho; Gabriela Geronimo; Talita Cesarim Mendonça; Fernando Freitas de Lima; Eneida de Paula
Journal:  Molecules       Date:  2021-11-17       Impact factor: 4.411

Review 3.  Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges.

Authors:  Sarah I Bukhari; Syed Sarim Imam; Mohammad Zaki Ahmad; Parameswara Rao Vuddanda; Sultan Alshehri; Wael A Mahdi; Javed Ahmad
Journal:  Pharmaceutics       Date:  2021-06-07       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.